Clarus Therapeutics Announces Notice of Allowance for Additi

Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO® (testosterone undecanoate)

Clarus Therapeutics Announces Notice of Allowance for Additional Patent Claims Covering JATENZO® (testosterone undecanoate)
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

United States , Kara Stancellvice , Robert Dudley , Exchange Commission , Trademark Office , Clarus Therapeutics Holdings Inc , Clarus Therapeutics Inc , Investor Relations Corporate Communications , Therapeutics Holdings , United States Patent , Testosterone Ester Formulations , Treating Testosterone Deficiency Comprising , Chief Executive Officer , Male Hypogonadism , Clarus Therapeutics Holdings , Inc Clarus Therapeutics Holdings , Clarus Therapeutics , Forward Looking Statementscertain , Kara Stancellvice President , Investor Relations , Corporate Communications , Prescribing Information ,